Condition Spotlight: Crohn’s & Colitis

Iron deficiency anemia is common in patients with Crohn’s disease and ulcerative colitis, but iron supplementation also could be an effective treatment.

Vitamin E has shown potential for targeting the underlying mechanisms of inflammatory bowel disease, but more research into its clinical application is needed.

Emerging evidence underscores the significant impact of diet on IBD development and treatment.

Targeted microbiota manipulation using probiotics, prebiotics, synbiotics, and fecal microbiota transplantation holds potential for IBD treatment.

Patients who develop CDP after IPAA often face significantly lower QOL with a higher risk of septic complications and pouch failure.

Patients with inflammatory bowel diseases often experience insomnia and various mental health conditions that healthcare providers should monitor.

Advances in the management of IBD may support a shift from hospital-based care to community-based care.

A study examining 20 years of data shows that race, ethnicity, and geography impact disease severity in patients with IBD.